Page 153 - Organ motion in children for high-precision radiotherapy - Sophie Huijskens

18. Kristensen I, Nilsson K, Agrup M et al. A dose based approach for evaluation of inter-observer variations in target delineation. Tech. Innov. Patient Support Radiat. Oncol. 2017; 3–4:41–47.
19. Versteijne E, Gurney-Champion OJ, van der Horst A et al. Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study. Radiat. Oncol. 2017; 12(1):58.
20. van Mourik AM, Elkhuizen PHM, Minkema D et al. Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines. Radiother. Oncol. 2010. doi:10.1016/j.radonc.2010.01.009.
21. Nijkamp J, De Haas-Kock DFM, Beukema JC et al. Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands. Radiother. Oncol. 2012. doi:10.1016/j.radonc.2011.08.011.
22. Deurloo KEI, Steenbakkers RJHM, Zijp LJ et al. Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy. Int. J. Radiat. Oncol. 2005; 61(1):228–238.
23. Alcorn SR, Chen MJ, Claude L et al. Practice patterns of photon and proton pediatric image guided radiation treatment: Results from an International Pediatric Research Consortium. Pract. Radiat. Oncol. 2014; 4(5):336–341.
24. Guerreiro F, Seravalli E, Janssens GO et al. Potential gain of MRI-guided IMRT planning versus current clinical CBCT-guided VMAT for Wilms’ tumor. Radiother. Oncol. 2018; 127(1):S884– S885.
25. Guerreiro F, Seravalli E, Janssens GO et al. Dosimetric comparison of VMAT and pencil beam scanning proton therapy for abdominal pediatric tumors. Radiother. Oncol. 2018; 127(1):S885-886.
26. De Kraker J, Graf N, Pritchard-Jones K. Nephroblastoma clinical trial and study SIOP 2001, Protocol. SIOP RTSG 2001.
27. SKION. DCOG NBL 2009 Treatment Protocol for Risk Adapted Treatment of Children with Neuroblastoma. 2015.
28. European paediatric Soft Tissue Sarcoma Study Group. Protocol for Localized Non- Rhabdomyosarcoma Soft Tissue Sarcoma. 2005.
29. EuroNet-Paediatric Hodgkin’s Lymphoma Group. First international Inter-Group Study for classical Hodgkin’s Lymphoma in Children and Adolescents. 2006.
30. van Herk M. Errors and margins in radiotherapy. Semin. Radiat. Oncol. 2004; 14(1):52–64.
31. McKenzie A, van Herk M, Mijnheer B. Margins for geometric uncertainty around organs at risk
in radiotherapy. Radiother. Oncol. 2002; 62(3):299–307.
32. Leroy R, Benahmed N, Hulstaert F et al. Proton Therapy in Children: A Systematic Review of
Clinical Effectiveness in 15 Pediatric Cancers. Int. J. Radiat. Oncol. Biol. Phys. 2016; 95(1):267–
278.
33. Kortmann R-D, Freeman C, Marcus K et al. Paediatric radiation oncology in the care of
childhood cancer: A position paper by the International Paediatric Radiation Oncology Society
(PROS). Radiother. Oncol. 2016; 119(2):357–360.
34. Bhatia S, Armenian SH, Armstrong GT et al. Collaborative Research in Childhood Cancer
Survivorship: The Current Landscape. J. Clin. Oncol. 2015; 33(27):3055–3064.
35. Kasper HB, Raeke L, Indelicato DJ et al. The Pediatric Proton Consortium Registry: A Multi-
institutional Collaboration in U.S. Proton Centers. Int. J. Part. Ther. 2014; 1(2):323–333.
36. Bouzid N, Valteau Couanet D, Bolle S. Impact of radiation therapy on outcome in high-risk
neuroblastoma. Radiother. Oncol. 2018; 127:S883.
37. Jo JH, Ahn SD, Choi EK et al. Patterns of Recurrence after Radiation Therapy for High-risk
Neuroblastoma. Radiother. Oncol. 2018; 127:S883.
38. Skamene S, Abish S, Mitchell D, Freeman C. Radiotherapy is Important for Local Control at
Primary and Metastatic Sites in Pediatric Rhabdomyosarcoma. Cureus 2015; 7(11):e388.
39. Gatcombe HG, Marcus RB, Katzenstein HM et al. Excellent Local Control From Radiation 150